Lion Corporation (TYO:4912)
1,704.50
-2.50 (-0.15%)
Jan 23, 2026, 3:30 PM JST
Lion Corporation Revenue
Lion Corporation had revenue of 105.49B JPY in the quarter ending September 30, 2025, with 2.89% growth. This brings the company's revenue in the last twelve months to 416.73B, up 2.18% year-over-year. In the year 2024, Lion Corporation had annual revenue of 412.94B with 2.53% growth.
Revenue (ttm)
416.73B
Revenue Growth
+2.18%
P/S Ratio
1.13
Revenue / Employee
54.45M
Employees
7,654
Market Cap
471.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.94B | 10.18B | 2.53% |
| Dec 31, 2023 | 402.77B | 12.90B | 3.31% |
| Dec 31, 2022 | 389.87B | 23.64B | 6.45% |
| Dec 31, 2021 | 366.23B | 10.88B | 3.06% |
| Dec 31, 2020 | 355.35B | 7.83B | 2.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.21T |
| Shiseido Company | 961.65B |
| Unicharm | 961.15B |
| Rohto Pharmaceutical | 333.80B |
| KOSE Holdings | 324.54B |
| Pola Orbis Holdings | 169.97B |
| Kobayashi Pharmaceutical | 163.18B |
| Pigeon | 108.66B |
Lion Corporation News
- 2 months ago - Q3 2025 Lion Corp Earnings Presentation Transcript - GuruFocus
- 2 months ago - Q2 2025 Lion Corp Earnings Presentation Transcript - GuruFocus
- 1 year ago - Full Year 2024 Lion Corp Earnings Presentation Transcript - GuruFocus
- 1 year ago - Japan’s Lion Shares Jump as Fund Takes Stake in Underperformer - BNN Bloomberg